https://www.selleckchem.com/pr....oducts/crt-0105446.h
13 [95% confidence interval, 0.03 to 0.24]). However, among studies adjusting for comorbidities, SES was inversely correlated with EOL expenditures (regression coefficient, -$150.94 [95% confidence interval, -$177.69 to -$124.19], 2015 United States Dollars (USD)). Higher ambulatory care and drug expenditure were consistently found among higher SES patients irrespective of whether or not comorbidity adjustment was employed. CONCLUSION Overall, an inequality leading to higher end-of-life expenditure for higher SES patients existed to
Like
Comment
Share
